Home WhiteSwell

WhiteSwell

In operation
Series B
ADHF Treatment Technology Developer

Basic Information

WhiteSwell, a startup focused on developing new treatments for acute decompensated heart failure (ADHF), is currently researching a novel technology to treat ADHF. This technology seeks an alternative pathway to remove excess fluid buildup caused by the heart's inability to pump effectively, helping ADHF patients stay out of the hospital.
WhiteSwell
--
15~50 people
January 01, 2014
--